India has approved two COVID-19 vaccines — Serum Institute of India’s ‘Covishield’ and Bharat Biotech’s ‘Covaxin’ — for emergency restricted use, regulatory body DCGI said on Sunday. Both vaccines have to be administered in two doses, and have to be stored at 2-8° C.
Over 1.03 crore people have tested positive for coronavirus in India alone, according to latest data.
You can track coronavirus cases, deaths and testing rates at the national and State levels here. A list of State Helpline numbers is available as well.
Here are live updates:
Vaccine approved
Covishield, Covaxin approved for emergency use
India’s drug regulatory body has approved the use of Oxford’s COVID-19 vaccine ‘Covishield’ and Bharat Biotech’s ‘Covaxin’ for restricted emergency use.
“The Subject Expert Committee of Central Drugs Standard Control Organisation (CDSCO) met on January 1 and 2, and made recommendations in respect of proposal for Restricted Emergency Approval of COVID-19 virus vaccine of M/s Serum…
